LIVER & BILE DUCT CANCER CARE

Advanced Liver Cancer Care in China

Liver cancer often develops quietly and is frequently diagnosed at an advanced stage or near major blood vessels. China has built the world’s most experienced liver cancer care teams, pioneering specialized techniques that shrink large, previously inoperable tumors down to a size where they can be safely removed or cured.

  • Primary Liver Cancer (HCC) & Bile Duct Cancers (Cholangiocarcinoma)
  • Large Tumors or Cancers Involving Critical Blood Vessels (Portal Vein)
  • Patients Told Their Tumors Are Inoperable or Beyond Standard Chemo
  • World's Highest Surgical Volume for Complex Liver Operations
  • Specialized Direct-Artery Tumor Infusion (HAIC) & Particle Radiation
  • Continuous Bilingual Clinical Coordination Throughout Your Stay

CONVERSION, RADIATION & SURGICAL MODALITIES

Key Liver Cancer Treatments in China

Direct arterial chemotherapy, carbon ion particle beams, and vascular reconstructive surgery for complex tumors.

Direct Artery Infusion (HAIC)

Delivers concentrated medication directly into the liver's tumor-feeding arteries, shrinking large tumors up to 20 times more effectively than regular IV chemo with far fewer side effects.
Learn More

Carbon Ion Particle Therapy

Heavy ion beams that blast tough liver tumors with pin-point accuracy, destroying cancer cells right next to sensitive blood vessels without harming healthy liver tissue.
Learn More

Complex Vascular Surgery

Advanced surgical techniques that remove tumors intertwined with major blood vessels and reconstruct the veins, turning hopeless cases into successful surgeries.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Liver Cancer Care

A specialized clinical pathway connecting international patients directly with world-class hepatobiliary centers in China.

China has established global leadership in advanced liver and bile duct cancer care, pioneering effective conversion regimens that combine Hepatic Arterial Infusion Chemotherapy (HAIC) with targeted therapies and PD-1 immunotherapy to dramatically shrink large or advanced tumors. Chinese tertiary centers perform the highest volume of anatomical liver resections and transplantations globally, offering solutions for complex cases often considered inoperable elsewhere.

Every patient is assigned a personal bilingual clinical coordinator who compiles your scans, blood work (AFP, PIVKA-II), and pathology for a preliminary tumor board review before you leave home. All treatment is billed directly at official hospital rates, with structured remote surveillance and telemedicine check-ins continuing after you return home.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload pathology reports, biomarker NGS profiles, and imaging scans through our confidential clinical intake portal.

02. Remote MDT Review

National Clinical Research Center oncology boards evaluate eligibility, target expression, and formulate a customized protocol.

03. Visa & Admission

Receive official hospital medical invitation letters, transparent pricing schedules, and expedited department admission.

04. Treatment & Follow-up

Inpatient cellular or particle therapy in ISO-GMP cleanrooms with dedicated bilingual escorts and remote post-discharge care.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Liver Cancer patients considering advanced treatment in China.

Hepatic Arterial Infusion Chemotherapy infuses high-dose medication directly into the liver’s blood supply over 48 hours, concentrating anti-tumor effect up to 200-fold in the tumor while minimizing body-wide toxicity.
Yes. Chinese hepatobiliary centers have developed dedicated conversion regimens pairing HAIC, targeted pills, and immunotherapy with surgical thrombectomy to safely remove advanced vascular invasions.
Carbon ion beams deliver immense, lethal double-strand DNA damage to radioresistant tumors while stopping abruptly before reaching adjacent healthy liver parenchyma or bile ducts.
Our specialized hepatobiliary multidisciplinary board reviews your contrast MRI/CT scans and blood tests within 24 to 48 hours.

LIVER & BILIARY CANCER PRE-ASSESSMENT

Request a Confidential Case Review for Liver Cancer

Upload your liver MRI/CT scans, blood tests (AFP/PIVKA-II), and medical history for an expert multidisciplinary evaluation.

    Liver Cancer